Frank Litvack
CIK 1310715 · CEO and Chairman · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$693.2K
Companies
4
Total Filings
24
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CAPR | Director | 180,054 | $3.85 | $693.2K | $0 | 18 | 2026-05-14 |
| CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted | Director | 200,000 | — | — | $0 | 2 | 2011-05-12 |
| CAPRICOR THERAPEUTICS, INC. (NLTX) Delisted | Director | 1,000 | $13.96 | $14.0K | $0 | 1 | 2009-09-28 |
| CONOR MEDSYSTEMS INC (CONR) Delisted | CEO and Chairman | 0 | — | — | $0 | 2 | 2007-02-02 |
Recent Filings · Page 2 of 3
24 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-06 | CAPR | Grant (A) | — | $0 | EDGAR |
| 2020-06-09 | CAPR | Grant (A) | — | $0 | EDGAR |
| 2020-02-14 | CAPR | Mixed | — | $0 | EDGAR |
| 2019-12-19 | CAPR | Grant (A) | +20,391 | $0 | EDGAR |
| 2019-08-09 | CAPR | Grant (A) | — | $0 | EDGAR |
| 2018-01-04 | CAPR | Grant (A) | — | $0 | EDGAR |
| 2017-01-04 | CAPR | Grant (A) | — | $0 | EDGAR |
| 2016-06-06 | CAPR | Grant (A) | — | $0 | EDGAR |
| 2015-03-05 | — | Grant (A) | — | $0 | |
| 2011-05-12 | CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.